New York State Common Retirement Fund’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.42M Hold
95,997
0.01% 991
2025
Q4
$5.71M Buy
95,997
+3,500
+4% +$191K 0.01% 981
2025
Q3
$5.01M Hold
92,497
0.01% 1066
2025
Q2
$5.08M Hold
92,497
0.01% 1063
2025
Q1
$6.54M Sell
92,497
-1,148
-1% -$77.2K 0.01% 923
2024
Q4
$6.16M Sell
93,645
-4,600
-5% -$308K 0.01% 1018
2024
Q3
$6.91M Sell
98,245
-201,334
-67% -$16.8M 0.01% 955
2024
Q2
$24.7M Buy
299,579
+2,530
+0.9% +$211K 0.03% 419
2024
Q1
$25.9M Sell
297,049
-17,690
-6% -$1.58M 0.03% 426
2023
Q4
$30.3M Sell
314,739
-16,537
-5% -$1.46M 0.04% 364
2023
Q3
$29.3M Buy
331,276
+29,043
+10% +$2.58M 0.04% 366
2023
Q2
$26.2M Sell
302,233
-2,505
-0.8% -$236K 0.03% 453
2023
Q1
$29.6M Sell
304,738
-12,607
-4% -$1.31M 0.04% 408
2022
Q4
$32.8M Sell
317,345
-64,922
-17% -$6.09M 0.05% 366
2022
Q3
$32.4M Sell
382,267
-4,904
-1% -$437K 0.05% 358
2022
Q2
$32.1M Sell
387,171
-9,338
-2% -$743K 0.04% 368
2022
Q1
$30.6M Buy
396,509
+114,048
+40% +$9.54M 0.03% 447
2021
Q4
$25M Buy
282,461
+3,673
+1% +$303K 0.03% 559
2021
Q3
$21.5M Sell
278,788
-144,826
-34% -$11.4M 0.02% 639
2021
Q2
$35.3M Sell
423,614
-325
-0.1% -$25.8K 0.04% 438
2021
Q1
$32M Sell
423,939
-32,951
-7% -$2.69M 0.04% 458
2020
Q4
$40.1M Sell
456,890
-29,400
-6% -$2.33M 0.04% 390
2020
Q3
$37M Buy
486,290
+47,487
+11% +$4.8M 0.05% 371
2020
Q2
$54.1M Buy
438,803
+15,316
+4% +$1.52M 0.07% 270
2020
Q1
$35.8M Buy
423,487
+24,398
+6% +$2.1M 0.05% 318
2019
Q4
$33.7M Sell
399,089
-4,600
-1% -$347K 0.04% 434
2019
Q3
$27.2M Buy
403,689
+71,689
+22% +$5.52M 0.03% 502
2019
Q2
$28.4M Sell
332,000
-2,400
-0.7% -$205K 0.04% 503
2019
Q1
$29.7M Sell
334,400
-50,025
-13% -$4.64M 0.04% 467
2018
Q4
$32.7M Sell
384,425
-90,990
-19% -$8.66M 0.05% 383
2018
Q3
$46.1M Hold
475,415
0.05% 340
2018
Q2
$44.8M Buy
475,415
+825
+0.2% +$72.2K 0.06% 331
2018
Q1
$38.5M Sell
474,590
-10,000
-2% -$858K 0.05% 406
2017
Q4
$43.2M Sell
484,590
-1,200
-0.2% -$104K 0.05% 374
2017
Q3
$45.2M Buy
485,790
+7,000
+1% +$619K 0.06% 336
2017
Q2
$43.5M Sell
478,790
-5,724
-1% -$521K 0.06% 336
2017
Q1
$42.5M Sell
484,514
-22,426
-4% -$2M 0.06% 344
2016
Q4
$42M Buy
506,940
+36,000
+8% +$3.1M 0.06% 328
2016
Q3
$43.6M Buy
470,940
+77,540
+20% +$7.3M 0.06% 314
2016
Q2
$30.6M Buy
393,400
+31,400
+9% +$2.67M 0.04% 438
2016
Q1
$29.9M Sell
362,000
-70,300
-16% -$5.72M 0.05% 426
2015
Q4
$45.3M Buy
432,300
+5,100
+1% +$533K 0.07% 284
2015
Q3
$45M Buy
427,200
+262,144
+159% +$35M 0.07% 276
2015
Q2
$22.6M Buy
165,056
+117,056
+244% +$14.5M 0.03% 543
2015
Q1
$5.98M Buy
48,000
+46,486
+3,070% +$4.93M 0.01% 1115
2014
Q4
$137K Sell
1,514
-32,323
-96% -$2.69M ﹤0.01% 1998
2014
Q3
$2.44M Sell
33,837
-18,463
-35% -$1.21M ﹤0.01% 1527
2014
Q2
$3.25M Sell
52,300
-54,600
-51% -$3.3M ﹤0.01% 1454
2014
Q1
$7.29M Hold
106,900
0.01% 1059
2013
Q4
$7.51M Buy
106,900
+14,400
+16% +$978K 0.01% 1035
2013
Q3
$6.68M Sell
92,500
-800
-0.9% -$53.2K 0.01% 1045
2013
Q2
$5.21M Buy
+93,300
New +$5.81M 0.01% 1074

Other funds holding BMRN